Maladie de Marek: vaccins polyvalents = Marek disease: polyvalent vaccinesBOUQUET, J. F.Point vétérinaire (Maisons-Alfort). 1986, Vol 18, Num 100, pp 477-481, issn 0335-4997Article

Myocarditis after triple immunisationAMSEL, S. G; HANUKOGLU, A; FRIED, D et al.Archives of disease in childhood. 1986, Vol 61, Num 4, pp 403-405, issn 0003-9888Article

Réflexions portant sur l'efficacité des nouveaux vaccins combinés. Discussion = Are the new combined vaccines efficacious ?BEGUE, P; BLANCHER, M. G; MOZZICONACCI, M. P et al.Bulletin de l'Académie nationale de médecine. 1998, Vol 182, Num 3, pp 567-579, issn 0001-4079Conference Paper

Evaluation of the reactogenicity and immunogenic potency of inactivated three-component influenza vaccine with the increased concentration of hemagglutinin in an immunization doseMARINICH, I. G; SHADRIN, A. S; SHAPOSHNIKOVA, V. I et al.Žurnal mikrobiologii, èpidemiologii i immunobiologii. 1991, Num 7, pp 58-61, issn 0372-9311Article

A vaccine against malaria: how far away is a magic shot?Africa health. 1987, Vol 10, Num 1, pp 14-15, issn 0141-9536Article

Vaccination antigrippale = Influenza vaccinationAYMARD, M.Virologie (Montrouge). 2002, Vol 6, pp S149-S160, issn 1267-8694, NSArticle

Développement des vaccins conjugués = Developemnt of conjugated vaccinesSOUBEYRAND, Benoit.MTP. Médecine thérapeutique pédiatrie. 2000, Vol 3, pp 25-27, issn 1286-5494, HS2Article

Live attenuated vaccine vectorsMEKALANOS, J. J.International journal of technology assessment in health care. 1994, Vol 10, Num 1, pp 131-142, issn 0266-4623Conference Paper

Vaccin polyvalent anti-Pseudomonas. Effets et mécanisme immunologique de la protectionSANG EUN LEE; YOUNG KYOON KIM.Sehur huidai hagsur ji. (Seoul journal of medicine). 1984, Vol 25, Num 3, pp 420-429, issn 0253-2972Article

Impact of a Pentavalent Combination Vaccine on Immunization Timeliness in a State Medicaid PopulationHAPPE, Laura E; LUNACSEK, Orsolya E; KRUZIKAS, Denise T et al.The Pediatric infectious disease journal. 2009, Vol 28, Num 2, pp 98-101, issn 0891-3668, 4 p.Article

Combined vaccines for Europe, pharmaceutical, regulatory and policy-makingaspectsANDRE, F; CHOLAT, J; FURMINGER, I et al.Biologicals (Print). 1994, Vol 22, Num 4, issn 1045-1056, 147 p.Conference Proceedings

Polyvalent recombinant antigens: a new vaccine strategyKINGSMAN, S. M; KINGSMAN, A. J.Vaccine. 1988, Vol 6, Num 4, pp 304-306, issn 0264-410XArticle

Immunocytochemical focus assay for potency determination of measles―mumps―rubella trivalent vaccineFUKUDA, A; HISHIYAMA, M; UMINO, Y et al.Journal of virological methods. 1987, Vol 15, Num 4, pp 279-284, issn 0166-0934Article

The impact of DTaP-IPV-HB vaccine on use of health services for young infantsTHOMPSON, Lindsay A; IRIGOYEN, Matilde; MATIZ, L. Adriana et al.The Pediatric infectious disease journal. 2006, Vol 25, Num 9, pp 826-831, issn 0891-3668, 6 p.Article

Développement du vaccin pneumocoque conjugué undécavalent = Devellopment of 11 serotype conjugated vaccinePLOTKIN, Stanley A.MTP. Médecine thérapeutique pédiatrie. 2000, Vol 3, pp 17-18, issn 1286-5494, HS2Article

Polyvalent vaccines in fish : The interactive effects of multiple antigensBUSCH, R. A.Developments in biological standardization. 1997, Num 90, pp 245-256, issn 0301-5149Conference Paper

Construction of Neisseria meningitidis strains carrying multiple chromosomal copies of the porA gene for use in the production of a multivalent outer membrane vesicle vaccineVAN DER LEY, P; VAN DER BIEZEN, J; POOLMAN, J. T et al.Vaccine. 1995, Vol 13, Num 4, pp 401-407, issn 0264-410XArticle

Immunogenicity of a polyvalent melanoma antigen vaccine in humansBYSTRYN, J.-C; ORATZ, R; HARRIS, M. N et al.Cancer. 1988, Vol 61, Num 6, pp 1065-1070, issn 0008-543XArticle

Indirect Effect of 7-Valent Pneumococcal Conjugate Vaccine on Pneumococcal Colonization among Unvaccinated Household Members. CommentaryMILLAR, Eugene V; WATT, James P; BRONSDON, Melinda A et al.Clinical infectious diseases. 2008, Vol 47, Num 8, pp 989-999, issn 1058-4838, 11 p.Article

Immune responses to pertussis antigens eight years after booster immunization with acellular vaccines in adultsNHU NGUYEN TRAN MINH; QIUSHUI HE; EDELMAN, K et al.Vaccine. 2000, Vol 18, Num 19, pp 1971-1974, issn 0264-410XArticle

Vaccination de l'enfant : Vaccinologie = Vaccination in childrenMALLET, E.La Revue du praticien (Paris). 1995, Vol 45, Num 12, pp 1500-1507, issn 0035-2640Article

Continuing global poliomyelitis morbidity and lacunae of trivalent poliovirus vaccinesARYA, S. C.Vaccine. 1988, Vol 6, Num 3, pp 213-214, issn 0264-410XArticle

Immunochemical and biochemical analysis of the polyvalent Pseudomonas aeruginosa vaccine PEVMACINTYRE, S; MCVEIGH, T; OWEN, P et al.Infection and immunity. 1986, Vol 51, Num 2, pp 675-686, issn 0019-9567Article

Quantitative analysis of 23-valent Pneumovax by automated rate nephelometrySALERNO, R. A; ODELL, C; MCCAULEY, J et al.Journal of biological standardization. 1984, Vol 12, Num 4, pp 447-450, issn 0092-1157Article

Immune response to the 7-valent pneumococcal conjugate vaccine in 30 asplenic childrenMIKOLUC, B; KAYHTY, H; BERNATOWSKA, E et al.European journal of clinical microbiology & infectious diseases (Print). 2008, Vol 27, Num 10, pp 923-928, issn 0934-9723, 6 p.Article